Brian Taylor Slingsby serves as Executive at Mineralys Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brian Taylor Slingsby has executed 3 insider transactions totaling $11.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 24, 2024 involved selling 550,000 shares valued at $7.2M.
Brian Taylor Slingsby currently holds 8,644,579 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Taylor Slingsby has been a net seller of MLYS stock. They have purchased $4.0M and sold $7.2M worth of shares.
Brian Taylor Slingsby's most recent insider trade was on Jul 24, 2024, when they sold 550,000 shares at $13.05 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 14, 2023 | MLYS | $4.0M | Purchase | 250,000 | $16.00 | Discretionary |